Skip to main content
. 2015 Jan 28;2015(1):CD001957. doi: 10.1002/14651858.CD001957.pub6

Ferley 1989.

Methods Randomised, placebo‐controlled trial of Oscillococcinum® in the treatment of influenza‐like illness
Participants 487 participants presenting in primary care with a complaint of influenza‐like illness
 Inclusion criteria: age older than 12 years; rectal temperature above 38 °C and at least 2 of headache, stiffness, lumbar and articular pain, shivers
 Exclusion criteria: duration more than 24 hours; immune deficiency; local infection; immunisation against influenza; depression; immunostimulant treatment
 Average age of Oscillococcinum/placebo groups: 34/35
 Males:females in Oscillococcinum/placebo groups: 93:127/97:129
Interventions Oscillococcinum® twice a day for 5 days
Outcomes Primary outcome measure (patient‐assessed): proportion of patients who recovered (defined as rectal temperature below 37.5 °C and complete resolution of all 5 symptoms) within 48 hours of treatment. Number of days to recovery; number of days to return to work; use of medication for pain or fever; use of medication for cough or sore throat; use of antibiotic medication; patient judgement of effectiveness of treatment
Notes Use of medication calculated from percentages given in text. Some minor inconsistencies between figures suggest a small amount of missing data
Specific outcomes (temperature, symptoms including cough, coryza and fatigue) not reported per se
Research setting: general practices in Rhône‐Alpes region, France
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk No information on actual randomisation method
Allocation concealment (selection bias) Unclear risk Insufficient information provided
Blinding of participants and personnel (performance bias) 
 All outcomes Low risk Identical presentation of active drug and placebo
Blinding of outcome assessment (detection bias) 
 All outcomes Unclear risk Insufficient information provided
Incomplete outcome data (attrition bias) 
 All outcomes Low risk Low rate of attrition (and similar rate per group)
Selective reporting (reporting bias) Unclear risk Specific outcomes not reported: temperature, symptoms including cough, coryza and fatigue
Other bias Low risk Study appears to be free of other sources of bias (e.g. baseline imbalance)